Himed and Adva Cera Partner to Create a Seamless Prototype-to-Production Path for 3D-Printed Bioceramic Medical Devices

73% of Americans Are Stressed and Many Are Turning to AI, Alcohol, and Social Media to Cope, New National Study Finds

Annals of Family Medicine: Researchers in China Examine Use of AI-Assisted Ultrasound by General Practitioners To Detect Carotid Artery Plaque

Rigel to Present at the Jefferies Global Healthcare Conference

TransCode Therapeutics Initiates Phase 2a Clinical Trial with TTX-MC138 in Patients with ctDNA Positive Colorectal Cancer

Lakewood-Amedex Expands Global IP Portfolio for Lead Candidate, Nu-3, Targeting Infected Diabetic Foot Ulcers

Is $16.50 Per Share a Fair Buyout Price for Select Medical Holdings (SEM) Shareholders? Kaskela Law Encourages SEM Shareholders to Contact the Firm to Discuss Their Rights and Options to Seek Additional Compensation

Blue Cross Blue Shield of Michigan and Michigan Medicine Reach Contract Agreement

"This Product Has Truly Been Such A Blessing For My Health!" Gundry MD MCT Wellness, A Fat-Burning, Energy-Boosting Solution, Ideal For National Senior Health & Fitness Day

FirstService Residential collaborates with Forbes Travel Guide to set a new standard in luxury residential living

Biohaven Reports Positive Clinical Biomarker and Patient Data: First MoDE and TRAP Extracellular Protein Degraders Achieve Deep, Rapid, Selective Lowering of Disease-Driving Antibodies in Graves' Disease and IgA Nephropathy

CordenPharma adquiere AmbioPharm para ampliar su capacidad global de producción de principios activos peptídicos

Veeva Announces Falcon, an Agentic Platform and Standard Agents to Deliver Agentic Labor in Drug Development

ixlayer Appoints Helmut Osorio as General Manager to Accelerate Direct-to-Patient Growth for Biopharma

Vanda Pharmaceuticals Announces Orphan Drug Designation in Japan for Imsidolimab in Generalized Pustular Psoriasis

Dizal's ZEGFROVY® (Sunvozertinib) New Drug Application Accepted and Granted Priority Review by China National Medical Products Administration for First-Line Treatment of EGFR Exon 20 Insertion-Mutated Non-Small Cell Lung Cancer

Nuvalent Announces Key Program and Business Updates, Strengthening Foundation for Global Leadership in ROS1- and ALK-positive NSCLC

Immunic Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer

Subtle Medical Receives FDA Clearance for SubtleHD™(PET), Next-Generation AI-Powered Image Acceleration and Enhancement Software

WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities

Foresee Pharmaceuticals Announces Completion of Casppian Phase 3 Study with Last Patient Last Visit and Confirms Topline Results: 94% of Patients Achieve LH Suppression with 6-Month Dosing Interval of Leuprolide Mesylate, also the acceptance of Casppian Study for Presentation at Endocrine Society, ENDO 2026 Medical Conference, as a Potential New Six-Month Treatment Option for Central Precocious Puberty

Only 65 percent of employers taking action on women's health at work but progress remains fragmented, reveals Kearney

Hansa Biopharma reports positive efficacy and safety results from Idefirix® European post authorization study in kidney transplantation

Europe Retail Pharmacy Market to Reach USD 396.17 Billion by 2032 Driven by Prescription Drug Demand and Hybrid Pharmacy Expansion

Press Advisory: Food Safety Advocate available to speak about recent E. coli Outbreak linked to Kebab Shop Restaurant

Regeneron Pharmaceuticals, Inc. (REGN) Investors: September 14, 2026 Lead Plaintiff Deadline in Class Action Lawsuit

As National Wellness Month Comes to a Close, Periodontal Specialist Reminds Patients That Wellness Includes Oral Health

Little Rock Selected for Largest American Kidney Patient Meeting

BD to Present at Wells Fargo 21st Annual Healthcare Conference

West to Participate in Upcoming Investor Conferences